Guoming Shi

15PUBLICATIONS
47CO-AUTHORS
Haematological tumoursMolecular targetsMedical mycologyGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 20, 2026
Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion.

|Apr 08, 2026
Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS-Mutant Cholangiocarcinoma.

Jian Lin, Chen Sang, Bin Xiang

|Dec 31, 2025
Tet2 deficiency-induced expansion of monocyte-derived macrophages promotes liver fibrosis.

Jiuxing Feng, Baitong Wu, Yu Li

|Dec 12, 2025
Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.

Zhou Lu, Huanchen Shi, Rongshan Gao

|Sep 29, 2025
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies.

Yinan Shen, Xinyan Jin, Wei Song

|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer.

Chen Liang, Mu Ye, Lei Yu

Pageof 3

Frequent Collaborators

5 joint publications

Jian Zhou

4 joint publications

Jia Fan

3 joint publications

Jia-Cheng Lu

3 joint publications

Xueli Bai